Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.360
-0.070 (-2.04%)
At close: May 29, 2026, 4:00 PM EDT
3.400
+0.040 (1.19%)
After-hours: May 29, 2026, 7:52 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.05 billion as of May 29, 2026. Its market cap has decreased by -66.81% in one year.
Market Cap
1.05B
Enterprise Value
2.45B
1-Year Change
-66.81%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.05B, an increase of 245.19%. That is a compound annual growth rate of 24.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.05B | -34.50% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow | 1.31B |
| Phibro Animal Health | 1.25B |
| Evotec SE | 1.10B |
| Collegium Pharmaceutical | 1.09B |
| Cronos Group | 1.07B |
| Xeris Biopharma Holdings | 1.06B |
| Pacira BioSciences | 913.66M |
| Eton Pharmaceuticals | 834.10M |